Acute vs chronic effects of L-dopa on bladder function in patients with mild Parkinson disease

被引:51
作者
Brusa, L.
Petta, F.
Pisani, A.
Moschella, V.
Iani, C.
Stanzione, P.
Miano, R.
Finazzi-Agro, E.
机构
[1] Univ Roma Tor Vergata, Neurol Clin, I-00100 Rome, Italy
[2] Univ Roma Tor Vergata, Urol Clin, I-00100 Rome, Italy
[3] Osped S Eugenio, UOC Neurol, Rome, Italy
[4] IRCCS Fdn S Lucia, Rome, Italy
关键词
LONG-DURATION RESPONSE; MULTIPLE SYSTEM ATROPHY; VOIDING DYSFUNCTION; AUTONOMIC DYSFUNCTION; LEVODOPA; APOMORPHINE; STANDARDIZATION; TERMINOLOGY; RECEPTORS;
D O I
10.1212/01.wnl.0000260605.12506.86
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To compare acute and chronic effects of L-dopa on bladder function in levodopa-naive Parkinson disease ( PD) patients who had urinary urgency. Methods: We evaluated 26 L-dopa-naive PD patients at a university-based PD center with a first urodynamic session with a double examination: in the off treatment condition and 1 hour after acute challenge with carbidopa/L-dopa 50/200 mg; then, a chronic L-dopa monotherapy was administered ( mean dose 300 +/- 150 mg). Two months later, patients underwent a second urodynamic session with a single evaluation 1 hour after the acute carbidopa/L-dopa challenge. Results: The first acute L-dopa challenge significantly worsened bladder overactivity ( neurogenic overactive detrusor contractions threshold [ NDOC-t; 32% of worsening] and bladder capacity [ BC; 22% of worsening]); on the contrary, L- dopa challenge during chronic administration ameliorated the first sensation of bladder filling ( FS; 120% of improvement), NDOCT- t ( 93% improvement), and BC ( 33% of improvement) vs the values obtained with acute administration. An 86% significant improvement of FS in comparison with the basal value was observed. Conclusions: The acute and chronic L- dopa effects may be due to the different synaptic concentrations or to the activation of postsynaptic mechanisms obtained by chronic administration.
引用
收藏
页码:1455 / 1459
页数:5
相关论文
共 29 条
[1]  
Abrams P, 2002, NEUROUROL URODYNAM, V21, P167, DOI 10.1002/nau.10052
[2]   Assessment of voiding dysfunction in Parkinson's disease by the international prostate symptom score [J].
Araki, I ;
Kuno, S .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2000, 68 (04) :429-433
[3]   EFFECTS OF APOMORPHINE AND L-DOPA ON THE PARKINSONIAN BLADDER [J].
ARANDA, B ;
CRAMER, P .
NEUROUROLOGY AND URODYNAMICS, 1993, 12 (03) :203-209
[4]   Increased D1 dopamine receptor signaling in levodopa-induced dyskinesia [J].
Aubert, I ;
Guigoni, C ;
Håkansson, K ;
Li, Q ;
Dovero, S ;
Barthe, N ;
Bioulac, BH ;
Gross, CE ;
Fisone, G ;
Bloch, B ;
Bezard, E .
ANNALS OF NEUROLOGY, 2005, 57 (01) :17-26
[5]  
BIANCHINE J R, 1976, Clinical Pharmacokinetics, V1, P313, DOI 10.2165/00003088-197601050-00001
[6]   Central acute D2 stimulation worsens bladder function in patients with mild Parkinson's disease [J].
Brusa, L ;
Petta, F ;
Pisani, A ;
Miano, R ;
Stanzione, P ;
Moschella, V ;
Galati, S ;
Agrò, EF .
JOURNAL OF UROLOGY, 2006, 175 (01) :202-206
[7]  
CHRISTMAS TJ, 1988, LANCET, V2, P1451
[8]  
COCKETT ATK, 1991, P 1 INT CONS BEN PRO, V2, P279
[9]  
Daniel S E, 1993, J Neural Transm Suppl, V39, P165
[10]  
DELAFUENTEFERNA.R, 2004, BRAIN, V17, P1